Antibody-based research applications are critical for biological discovery. Yet there are no industry standards for comparing the performance of antibodies in various applications. We describe a knockout cell line-based antibody characterization platform, developed and approved jointly by industry and academic researchers, that enables the systematic comparison of antibody performance in western blot, immunoprecipitation and immunofluorescence.
View Article and Find Full Text PDFInfections are a significant cause of morbidity and mortality in myelodysplastic syndrome (MDS). Precise estimates of infection frequency and severity with modern therapies are uncertain. We conducted a retrospective analysis of a prospective cohort enrolled in a Canadian MDS registry and characterized the frequency and severity of infectious complications.
View Article and Find Full Text PDFMyelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are severe myeloid disorders associated with significant morbidity and mortality. Because of patient and disease factors, many older adults are treated as outpatients with less-intensive therapy. Optimal supportive care strategies to minimize bleeding and infectious complications in this patient population have not been systematically evaluated.
View Article and Find Full Text PDFWayfinding is the process of navigating from one's present location to their desired location. While wayfinding technologies are increasingly used by people with disabilities, there is little understanding of the barriers specific to wayfinding technology. The objective of this study was to understand the wayfinding technology barriers experienced by Canadians with disabilities.
View Article and Find Full Text PDFObjectives: We developed a novel measure for older U.S. adults called the Nutrition Equity Index (NEI), which includes functional ability.
View Article and Find Full Text PDF